GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer
ONCOLOGY · 06.08.2025 · (3907) · 294-296
DOI: 10.46883/2025.25921046 ↗Kurz gefasst
Fachartikel in der Zeitschrift ONCOLOGY, online erschienen am 12.08.2025. Verfasst von Sherry Shen und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Neoplasms, Glucagon-Like Peptide-1 Receptor Agonists, Weight Gain. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
Obesity and weight gain are associated with adverse outcomes following breast cancer diagnosis; some breast cancer treatments contribute to postdiagnosis weight gain. We evaluated patients with breast cancer who were prescribed a glucagon-like peptide-1 receptor agonist (GLP-1 RA), with follow-up weight data available. Weights were categorized by time from GLP-1 RA initiation; a linear mixed effects model with a random intercept for baseline weight was used to assess mean weight change at each time point. Among 75 patients, the median age was 52 years (range, 27-74), 62 (86%) were postmenopausal, and 59 (79%) had diabetes. Additionally, 68 (91%) patients had stage 0 to III breast cancer, and 62 (84%) had estrogen receptor–positive disease. The median body mass index (BMI) at baseline was 34 (range, 23-50). The mean weight change was –2.9 kg (95% CI, –4.1 to –1.7) at 6 months and –4.2 kg (95% CI, –5.5 to –2.9) at 12 months; mean weight change at 12 months was –5% (95% CI, –6% to –3%). In univariable and multivariable analyses, age, baseline BMI, diabetes, stage, histology, receptor status, menopausal status, and concurrent endocrine therapy use were not significantly associated with 5% or greater weight loss at 12 months. These results support the development of clinical trials to optimize the use and dosing of GLP-1 RAs for weight loss in patients with breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Shen, S., Bethina Liu Md, Chad Fanti Md, Maria Bromberg Mph, Yuan Chen PhD, Cassandra Chang, & Neil M Iyengar Md (2025). GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer. ONCOLOGY, 294-296. https://doi.org/10.46883/2025.25921046
Vancouver
Shen S, Bethina Liu Md, Chad Fanti Md, Maria Bromberg Mph, Yuan Chen PhD, Cassandra Chang, et al. GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer. ONCOLOGY. 2025:294-296. doi:10.46883/2025.25921046
BibTeX
@article{Shen2025,
author = {Shen, Sherry and Bethina Liu Md and Chad Fanti Md and Maria Bromberg Mph and Yuan Chen PhD and Cassandra Chang and Neil M Iyengar Md},
title = {GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer},
journal = {ONCOLOGY},
year = {2025},
number = {3907},
pages = {294--296},
doi = {10.46883/2025.25921046}
}
EUVIMED